Well, actually it doesn't suck as much as the alternatives. Instead of raising the A/S to 10 billion to give DNA potential access to $400,000 more in funding (based on the current PPS of $0.0001), Adrian could have done any of the following:
1) Do a 1:1,000 reverse split to lower the O/S to 6 million while retaining the A/S at 6 billion, thus killing the positions of current shareholders, but giving DNA 5.4 billion shares of dilution headspace.
2) Pray for an investor to put money in to DNA without being given any shares.
3) Do nothing.
The company is out of inventory and out of cash. If the company is going to reboot the business, it MUST raise capital somehow.
This move to a higher A/S demonstrates that the new management intended to move forward instead of waiting for a miracle to occur.
I think I may buy another 10 million shares just to show my support and approval of Adrian's efforts.
Market Data 
Markets 
AI
